In severe liver disease, citrate can be used safely: the question remains—by which mechanism

Detalles Bibliográficos
Autores principales: Honore, Patrick M., Mugisha, Aurore, David, Cristina, Attou, Rachid, Redant, Sebastien, Gallerani, Andrea, De Bels, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038605/
https://www.ncbi.nlm.nih.gov/pubmed/32093726
http://dx.doi.org/10.1186/s13054-020-2801-2
_version_ 1783500677388959744
author Honore, Patrick M.
Mugisha, Aurore
David, Cristina
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
De Bels, David
author_facet Honore, Patrick M.
Mugisha, Aurore
David, Cristina
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
De Bels, David
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-7038605
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70386052020-03-02 In severe liver disease, citrate can be used safely: the question remains—by which mechanism Honore, Patrick M. Mugisha, Aurore David, Cristina Attou, Rachid Redant, Sebastien Gallerani, Andrea De Bels, David Crit Care Letter BioMed Central 2020-02-24 /pmc/articles/PMC7038605/ /pubmed/32093726 http://dx.doi.org/10.1186/s13054-020-2801-2 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Honore, Patrick M.
Mugisha, Aurore
David, Cristina
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
De Bels, David
In severe liver disease, citrate can be used safely: the question remains—by which mechanism
title In severe liver disease, citrate can be used safely: the question remains—by which mechanism
title_full In severe liver disease, citrate can be used safely: the question remains—by which mechanism
title_fullStr In severe liver disease, citrate can be used safely: the question remains—by which mechanism
title_full_unstemmed In severe liver disease, citrate can be used safely: the question remains—by which mechanism
title_short In severe liver disease, citrate can be used safely: the question remains—by which mechanism
title_sort in severe liver disease, citrate can be used safely: the question remains—by which mechanism
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038605/
https://www.ncbi.nlm.nih.gov/pubmed/32093726
http://dx.doi.org/10.1186/s13054-020-2801-2
work_keys_str_mv AT honorepatrickm insevereliverdiseasecitratecanbeusedsafelythequestionremainsbywhichmechanism
AT mugishaaurore insevereliverdiseasecitratecanbeusedsafelythequestionremainsbywhichmechanism
AT davidcristina insevereliverdiseasecitratecanbeusedsafelythequestionremainsbywhichmechanism
AT attourachid insevereliverdiseasecitratecanbeusedsafelythequestionremainsbywhichmechanism
AT redantsebastien insevereliverdiseasecitratecanbeusedsafelythequestionremainsbywhichmechanism
AT galleraniandrea insevereliverdiseasecitratecanbeusedsafelythequestionremainsbywhichmechanism
AT debelsdavid insevereliverdiseasecitratecanbeusedsafelythequestionremainsbywhichmechanism

Ejemplares similares